An examination of the moderating effects of neurophysiology on treatment outcomes from cognitive training in schizophrenia-spectrum disorders

被引:5
|
作者
Best, Michael W. [1 ]
Milanovic, Melissa [1 ]
Shamblaw, Amanda L. [1 ]
Muere, Abi [1 ]
Lambe, Laura J. [1 ]
Hong, Irene K. [1 ]
Haque, Mashal K. [1 ]
Bowie, Christopher R. [1 ,2 ]
机构
[1] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada
[2] Ctr Addict & Mental Hlth, Toronto, ON, Canada
关键词
CATECHOL-O-METHYLTRANSFERASE; WORKING-MEMORY; FRONTAL THETA; NEUROCOGNITIVE DEFICITS; EXECUTIVE FUNCTION; EEG-ALPHA; REMEDIATION; METAANALYSIS; PERFORMANCE; SYNCHRONIZATION;
D O I
10.1016/j.ijpsycho.2019.02.004
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Impairments in neurocognition and community functioning are core features of schizophrenia and cognitive training techniques have been developed with the aim of improving these impairments. While cognitive training has produced reliable improvements in neurocognition and functioning, little is known about factors that moderate treatment response. Electroencephalographic (EEG) measures provide a neurophysiological indicator of cognitive functions that may moderate treatment outcomes from cognitive training. Methods: Data from a clinical trial comparing two cognitive training approaches in schizophrenia-spectrum disorders were utilized in the current report. Cluster analysis was conducted to identify participant clusters based on baseline P300, mismatch negativity (MMN), and theta power during an n-back task, and the EEG measures were also examined as continuous predictors of treatment response. Results: Three clusters were identified based on the baseline EEG variables; however, there were no significant differences in treatment response across the three clusters. Higher P300 amplitude and theta power during the n-back at baseline were significantly associated with greater improvements in a cognitive composite score post-treatment. None of the EEG measures were significantly associated with treatment outcomes in specific cognitive domains or community functioning. Change in EEG measures from baseline to post-treatment was not significantly associated with durability of cognitive or functional change at 12-week follow-up. Conclusions: Clusters derived from the EEG measures were not significantly associated with either neurocognitive or functional outcomes. P300 and n-back theta power may be associated with learning-related processes, which are important for acquisition and retention of skills during cognitive training programs. Future research should aim to identify at an individual level who is likely to respond to specific forms of cognitive enhancement.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 37 条
  • [1] Remote group therapies for cognitive health in schizophrenia-spectrum disorders: Feasible, acceptable, engaging
    Mendelson, Daniel
    Thibaudeau, Elisabeth
    Sauve, Genevieve
    Lavigne, Katie M.
    Bowie, Christopher R.
    Menon, Mahesh
    Woodward, Todd S.
    Lepage, Martin
    Raucher-Chene, Delphine
    SCHIZOPHRENIA RESEARCH-COGNITION, 2022, 28
  • [2] Motivation and engagement during cognitive training for schizophrenia spectrum disorders
    Best, Michael W.
    Milanovic, Melissa
    Tran, Tanya
    Leung, Pauline
    Jackowich, Robyn
    Gauvin, Stephanie
    Leibovitz, Talia
    Bowie, Christopher R.
    SCHIZOPHRENIA RESEARCH-COGNITION, 2020, 19
  • [3] Do clinical characteristics predict the cognitive course in early-onset schizophrenia-spectrum disorders?
    Teigset, Charlotte M.
    Mohn, Christine
    Brunborg, Cathrine
    Juuhl-Langseth, Monica
    Holmen, Aina
    Rund, Bjorn Rishovd
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2018, 59 (09) : 1012 - 1023
  • [4] Is modafinil an effective adjunct to standard care in the treatment of schizophrenia-spectrum disorders?
    Oyesanya, Mayowa
    Al-Juffali, Noura
    BJPSYCH ADVANCES, 2022, 28 (05) : 281 - 285
  • [5] Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders
    Brand, Bodyl A.
    Boer, Anne Jetske
    de Boer, Janna N.
    Bozaoglu, Kiymet
    Morris, Kim
    Rossell, Susan
    Sommer, Iris E. C.
    PSYCHONEUROENDOCRINOLOGY, 2025, 172
  • [6] Personalised treatment for cognitive dysfunction in individuals with schizophrenia spectrum disorders
    Medalia, Alice
    Saperstein, Alice M.
    Hansen, Marie C.
    Lee, Seonjoo
    NEUROPSYCHOLOGICAL REHABILITATION, 2018, 28 (04) : 602 - 613
  • [7] The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disorders
    Oomen, P. P.
    Gangadin, S. S.
    Begemann, M. J. H.
    Visser, E.
    Mandl, R. C. W.
    Sommer, I. E. C.
    SCHIZOPHRENIA RESEARCH, 2022, 241 : 228 - 237
  • [8] A Randomized Controlled Trial of Executive Functioning Training Compared With Perceptual Training for Schizophrenia Spectrum Disorders: Effects on Neurophysiology, Neurocognition, and Functioning
    Best, Michael W.
    Milanovic, Melissa
    Iftene, Felicia
    Bowie, Christopher R.
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (04) : 297 - 306
  • [9] Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review
    Perrottelli, Andrea
    Giordano, Giulia Maria
    Brando, Francesco
    Giuliani, Luigi
    Pezzella, Pasquale
    Mucci, Armida
    Galderisi, Silvana
    DIAGNOSTICS, 2022, 12 (09)
  • [10] The efficacy of computerized cognitive drill and practice training for patients with a schizophrenia-spectrum disorder: A meta-analysis
    Prikke, Merel
    Konings, Mette J.
    Lei, Wan U.
    Begemann, Marieke J. H.
    Sommer, Iris E. C.
    SCHIZOPHRENIA RESEARCH, 2019, 204 : 368 - 374